PixarBio (PXRB) Starts Presentation at LD Micro Main Event
PixarBio (OTC: PXRB) is a specialty pharmaceutical company focused on pre-clinical and commercial development of novel neurological drug delivery systems for post-operative pain. The company researches and develops targeted delivery systems for drugs, cells, or biologics to treat pain, epilepsy, Parkinson's disease, and spinal cord injury. The company's lead product platform, NeuroRelease, is an extended drug release microparticle platform that is non-opiate, non-addictive for post-surgical pain treatment. In pre-clinical models, NeuroRelease has the potential to achieve six months of sustained therapeutic release of non-opiate drugs for post-operative, acute and chronic pain. For more information, visit the company's website at www.pixarbio.com.…







